Discover the detailed record of transactions filed by DeFord John A, 董事. Director active across 4 companies, notably NORDSON CORP. Cumulatively, 33 disclosures have been recorded. Breakdown: 1 buy · 4 sells. Total volume traded: €94k. History available since 30 April 2021. The latest transaction was disclosed on 31 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to DeFord John A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
DeFord John A is a Director at NORDSON CORP, Maravai Lifesciences Holdings, INC. and Globus Medical INC, and he is also Sr. VP Sci Tech and Clin Afrs at BARD C R INC /NJ/. Across 32 filings in total, the 32 sampled filings run from 2016-02-10 to 2026-05-28, with EUR 94356 in buys and EUR 0 in sells, and the most common transaction nature is Attribution.